Annals of Family Medicine
NOVEMBER 20, 2024
A patient partner from the Deaf community collaborated on each step of this project. ’s (2006) narrative synthesis was used to analyze and report the results. A community consultation identified the evaluation of the cost of providing sign language interpreters (or not) as a top research priority. Popay et al.’s
Annals of Family Medicine
NOVEMBER 20, 2024
This can potentially compromise their ability to provide optimal patient care. ’s (2006) framework. Family physicians' pivotal role in prevention and crisis management exposes them to mental stressors due to the highly demanding circumstances.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Today's Hospitalist
MAY 16, 2025
WITH PATIENT ACUITY levels rising in hospitals, it makes sense that the patients being discharged to SNFs are likewise increasingly complex. By some estimates, one in four patients discharged to a SNF are readmitted. That’s when the health system turned to a company that provides a turnkey SNF-care program.
FDA Law Blog
MARCH 7, 2024
Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.
StorytellERdoc
JULY 10, 2014
Lately, though, it seems the system meant to provide this care is being bogged down by questionable decision-making. Instead of providing emergent care, it seems I spend at least half of my emergency room time now playing doctor to chronic illnesses. To pain control issues. A month back, I was in the middle of a very busy shift.
Today's Hospitalist
APRIL 24, 2025
Those interventions included standardizing both bed assignments and nursing handoffs while having ED providers—not an inpatient team—enter skeletal orders when deciding to admit a patient. Such delays can compromise patient care by increasing mortality, medical errors and length of stay.
FDA Law Blog
DECEMBER 12, 2022
Shapiro — Last summer, FDA published a draft guidance, Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations (July 29, 2022) setting forth a proposal for new recommended patient‑directed labeling. The approved devices already have patient‑directed labeling that FDA has approved. By Jeffrey K.
Expert insights. Personalized for you.
130 
Let's personalize your content